Molecule Information
General Information of the Molecule (ID: Mol00838)
Name |
Beta-lactamase (BLA)
,Escherichia coli
|
||||
---|---|---|---|---|---|
Synonyms |
Penicillinase; oxa2
Click to Show/Hide
|
||||
Molecule Type |
Protein
|
||||
Gene Name |
bla
|
||||
Gene ID | |||||
Sequence |
MAIRIFAILFSIFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQADRAMLVFD
PVRSKKRYSPASTFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNS TVWVYELFAKEIGDDKARRYLKKIDYGNADPSTSNGDYWIEGSLAISAQEQIAFLRKLYR NELPFRVEHQRLVKDLMIVEAGRNWILRAKTGWEGRMGWWVGWVEWPTGSVFFALNIDTP NRMDDLFKREAIVRAILRSIEALPPNPAVNSDAAR Click to Show/Hide
|
||||
Function |
This is an oxacillin-hydrolyzing beta-lactamase.
Click to Show/Hide
|
||||
Uniprot ID | |||||
Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
DISM: Drug Inactivation by Structure Modification
Drug Resistance Data Categorized by Drug
Approved Drug(s)
2 drug(s) in total
Amoxicillin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Drug Inactivation by Structure Modification (DISM) | ||||
Disease Class: Gram-negative bacterial infection | [1], [2] | |||
Resistant Disease | Gram-negative bacterial infection [ICD-11: 1B74-1G40] | |||
Resistant Drug | Amoxicillin | |||
Molecule Alteration | Expression | Up-regulation |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli | 668369 | ||
Acinetobacter johnsonii LIM75 | 40214 | |||
Aeromonas allosaccharophila LIM82 | 656 | |||
Citrobacter freundii LIM86 | 546 | |||
Escherichia coli MFDpir | 562 | |||
Experiment for Molecule Alteration |
Whole genome sequence assay | |||
Experiment for Drug Resistance |
Agar dilution method assay; broth microdilution method assay | |||
Mechanism Description | All known class 3 integrons harbour gene cassettes encoding resistance to Beta-lactams (blaIMP, blaGES, blaBEL, blaOXA-256) and aminoglycosides [aac(6')-Ib]. |
Ceftazidime
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Drug Inactivation by Structure Modification (DISM) | ||||
Disease Class: Gram-negative bacterial infection | [1], [2] | |||
Resistant Disease | Gram-negative bacterial infection [ICD-11: 1B74-1G40] | |||
Resistant Drug | Ceftazidime | |||
Molecule Alteration | Expression | Up-regulation |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli | 668369 | ||
Acinetobacter johnsonii LIM75 | 40214 | |||
Aeromonas allosaccharophila LIM82 | 656 | |||
Citrobacter freundii LIM86 | 546 | |||
Escherichia coli MFDpir | 562 | |||
Experiment for Molecule Alteration |
Whole genome sequence assay | |||
Experiment for Drug Resistance |
Agar dilution method assay; broth microdilution method assay | |||
Mechanism Description | All known class 3 integrons harbour gene cassettes encoding resistance to Beta-lactams (blaIMP, blaGES, blaBEL, blaOXA-256) and aminoglycosides [aac(6')-Ib]. |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.